GlassScriptPrepare for your visit
Brian D Rotskoff
Allergy · Chicago, IL · NPI 1285662304
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$82,150.19
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 6 by amount.
- Regeneron Healthcare Solutions, INC. $46,395.93
- Genzyme Corporation $33,633.49
- Astrazeneca Pharmaceuticals LP $776.07
- Glaxosmithkline, LLC. $637.54
- Amgen INC. $218.36
- Biocryst US Sales Co., LLC $163.89
Drugs and devices associated with these payments
Dupixent Tezspire Cibinqo Daliresp Nucala Orladeyo Airsupra Trelegy Ellipta
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Brian Rotskoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/627012/brian-d-rotskoff